Immunohistochemical Detection of Hepatitis B Core Antigen in the Bile Duct Epithelia by Senba Masachika & Baba Sumiko
Acta Med. Nagasaki 35:88-91
Immunohistochemical Detection of Hepatitis B Core Antigen 
             in the Bile Duct Epithelia
Masachika SENBA* and Sumiko BABA**
 *Department of Pathology, Institute of Tropical Medicine, 
  Nagasaki University, Nagasaki 852, Japan 
 ** Department of Obsterics and Genecology, Nagasaki University 
  Hospital, Nagasaki 852, Japan
Received for publication, June 25, 1990
SUMMARY : One hundred liver specimens of hepatitis B surface antigen positive 
cases were used for this study. The localization of hepatitis B core antigen in the bile 
duct epithelia was investigated by immunoperoxidase method. In three cases, hepatitis 
B core antigen was detected not only in the nuclei of the bile duct epithelia, but also 
in the cytoplasms of the bile duct epithelia. These findings suggested that hepatitis B 
virus may replicate in the bile duct epithelia. The resons for distribution of hepatitis 
B core antigen in the nuclei of the bile ducts are not known. A possible explanation 
may be that intrahepatic bile ducts develop from hepatocytes. To the best of our 
knowledge, morphologic localization of hepatitis B core antigen in the nuclei of the bile 
duct epithelia has not been reported previously.
       INTRODUCTION 
 In 1965, Blumberg and collegues found an 
antibody in patients with viral hepatitis which 
react with an antigen in a single serum of 
Australian aborigine. Therefore, this antigen 
was called Australia antigen.') In 1977, 
Blumberg was awarded the Nobel prize for his 
discovery. Australia antigen is now known to 
be the surface of the hepatitis B virion and is 
termed hepatitis B surface antigen. Hepato-
cellular carcinoma becomes clinically manifest 
after cirrhosis has been well formed, and the 
major factor predisposing hepatocellular 
carcinoma in a population appears to be the 
presence of cirrhosis caused by chronic hepatitis 
B virus in the development of hepatocellular 
carcinoma.") 
 Hepatitis B virus infection is a significant 
public health problem in many countries. In
Asian countries where infection with hepatitis 
B virus is hyperendemic, most people are 
infected during childhood through either 
mother-to-newborn ro child-to-child transmis-
sion. Antigenaemia develops in the baby within 
two months of birth and tends to persist. The 
peak incidence is in chilhood rather than in 
neonates. In such areas, including Africa, 
Greece, and Hong Kong intra-family spread 
seems particularly important. In the United 
States of America, hepatitis B virus infection 
is over 200,000 incidents of new infection of 
hepatitis B virus each year and 12,000 to 20,000 
Americans annually join the ranks of chronic 
carriers. 1) The most effective procedure for 
controlling hepatitis B virus is the vaccination 
of newborn infants .8, .1,24> However, the current 
strategy of targeting high-risk groups for 
vaccination has not reduced the incidence of 
hepatitis B, and it has no chance of eradicating 
the disease in the United States of America.10>
At Nagasaki in Japan, long-term trend of 
decreasing frequency of hepatitis B virus 
infection has been suggested.") 
 Histological location of hepatitis B core 
antigen in the bile duct epithelia has not been 
reported previously. Therefore, we investigated 
the morphologic localization of hepatitis B core 
antigen in extrahepatocyte areas. We present 
here the immunohistochemical findings of three 
autopsy cases with hepatitis B core antigen in 
the bile duct epithelia. 
   MATERIALS AND METHODS 
 The liver specimens from 100 autopsy cases 
associated with hepatitis B surface antigen 
positive at Nagasaki University Hospital were 
collected. These tissues were fixed in 10% 
formalin solution, dehydrated and embedded in 
paraffin. Sections were cut at four micron 
thickness for hematoxylin and eosin, Mallory's 
for collagen fibers, and silver impregnation for 
reticulum fibers stainnings. For immuno-
histochemistry, the sections were stained with 
anti-hepatitis B core antiserum (Dako PAP Kit) 
by using the peroxidase-anti-peroxidase (PAP) 
method. 
 The steps involved in the immunoperoxidase 
method for hapatitis B core antigen are as 
following : (1) Deparaffinize and hydrate in 
distilled water. (2) Treat with hydrogen 
peroxidase for 10 minutes in a 37CC incubator. 
(3) Wash in distilled water. (4) Wash in Tris 
buffer pH 7.4 using three cycle changes of 3 
minutes each. (5) Treat with normal swine 
serum for 40 minutes in a 37CC incubator. (6) 
Tap off excess. (7) Treat with anti-hepatitis B 
core antibody (Dako) for 2 hours in a 37CC 
incubator. (8) Wash in Tris buffer pH 7.4 using 
three cycle changes of 5 minutes each. (9) Treat 
with swine anti-rabbit for 40 minutes in a 37CC 
incubator. (10) Wash in Tris buffer pH 7.4 using 
three cycle changes of 3 minutes each. (11) Treat 
with PAP for 40 minutes in 37'C incubator. 
(12) Wash in Tris buffer pH 7.4 using three cycle 
changes of 3 minutes each. (13) Treat with 
aminoethylcarbazole (AEC) as substrate 
solution for 40 minutes at room temperature. 
(14) Wash in distilled water. (15) Counterstain 
with Mayer's hematoxylin for 5 minutes. (16)
Wash in distilled water. (17) Mount with glycerol 
gelatin (Sigma).
          RESULTS 
 Immunohistochemical staining of hepatitis B 
core antigen resulted in red brown reaction 
products with AEC. In the bile duct epithelia 
three (3%) were hepatitis B core antigen positive 
out of 100 cases. Most of hepetitis B core antigen 
was localized in the nuclei of bile duct epithelia, 
sometimes it was localized in the cytoplasms 
(Figs. 1 and 2). Moreover, Immunoperoxidase 
investigation indicated that large number of 
hepatitis B core antigen was observed in the 
nuclei of hepatocytes and in the cytoplasms of 
hepatocytes (Fig. 3).
Fig. 1. Hepatitis B core antigen is localized in the 
      nuclei of the bile duct epithelia (arrows).
      (Immunoperoxidase for hepatitis B core 
      antigen, x 400).
Fig. 2. Highter magnification of figure 1. Rarely 
      hepatitis B core antigen is localized in the 
      cytoplasm of the bile duct epithelium 
      (square arrow), but most of hepatitis B core 
      antigen is localized in the nuclei of the bile 
      duct epithelia (arrows). (Immunoperoxidase
      for hepatitis B core antigen, X400).
Fig. 3. Hepatitis B core antigen is observed in the 
      nuclei of hepatocytes and also in the
       cytoplasms of hepatocytes. (Immuno-
       peroxidase for hepatitis B core antigen, x 
     400).
         DISCUSSION 
 The present study confirms the possibility of 
infection and replication of hepatitis B virus in 
the bile duct epithlia. It is suggested that 
hepatitis B virus has an affinity not only for 
the hepatocytes but also other cells. Based on 
light and electron microscopic studies, it has 
been suggested that intrahepatic bile duct cells 
develop from hepatocytes.5> In contrast, other 
investigators have hypothesized that intra-
hepatic bile duct development occurs from 
ingrowth of epithelium of the extrahepatic bile 
ducts,'' whereas some authors have proposed 
a combination of the two theories.") By cyto-
keratin immunohistochemistry, the develop-
ment of the intrahepatic bile duct was studied 
in rat and human liver specimens.", 1,21) It is 
concluded that the intrahepatic bile ducts 
develop from hepatocytes. Therefore, hepatitis 
B core antigen may replicate in the hepatocytes 
as well as in the bile duct epithelia. 
 The liver is thought to be the primary site 
of hepatitis B virus replication and synthesis. 
Hepatitis B virus antigen have been shown to 
be associated with both intrahepatic and 
extrahepatic diseases. Hepatitis B virus in-
fection is association with the production of 
tissue damage outside the liver. Hepatitis B 
surface antigen and/or hepatitis B surface 
antigen immune complexes have shown in ex 
trahepatic localizations in renal glomeruli,3" 17) 
wall of vessels,") bone marrow and pancre-
as. 18,23,25) Localization of hepatitis B surface 
antigen in hepatocellular carcinoma has been 
reported. 13,15,16,19, 26) Hepatitis B virus concen-
trated samples of saliva, urine and seminal fluid 
from HBeAg-positive male have shown the 
presence of HBV-DNA by molecular hybridi-
zation. 1L1
         REFERENCES 
1) Arevalo JA, Washington E : Cost-effectiveness 
   of prenatal screening and immunization for 
  hepatitis B virus. JAMA, 259:365-369, 1988. 
2) Blumberg BS, Alter HJ, Visnich S : A "New" 
   antigen in leukemia sera. JAMA, 191 :101-105, 
  1965. 
3) Brozosko WJ, Krawczynski K, Nazarewicz T, 
   Morzycka M, Nowoslawski A : Glomerulone-
   phritis associated with hepatitis B surface 
   antigen immune complexes in children. Lancet, 
  ii : 477-482, 1974. 
4) Carthew P, Edwards RE, Hill RJ, Evans JG : 
   Cytokeratin expression in cells of the rodent bile 
   duct developing under normal and pathological 
   conditions. Br. J. Exp. Med., 70:717-725, 1989. 
5) Enzan H, Ohkita T, Fujita H, lijima S : Light 
   and electron microscopic studies on the 
   development of periportal bile ducts of the 
   human embryo. Acta Pathol. Jpn., 24:427--447, 
  1974. 
6) Eyken P, Sciot R, Dame B, Wolf-Peeters C, 
  Desmet VJ : Keratin immunohistochemistry in 
   normal human liver. Cytokeratin pattern of 
   hepatocytes, bile ducts and acinar gradient. 
   Virchows Arch. A, 412: 63-72, 1987. 
7) Eyken P, Sciot R, Desmet V : lntrahepatic bile 
   duct development in the rat. A cytokeratin-
   immunohistochemical study. Lab. Invest., 59: 52-
  59, 1988. 
8) Franks AL, Berg CJ, Kane MA, Browne BB, Sikes 
   RK, Elsea WR, Burton AH : Hepatitis B virus 
   infection among children born in the United 
   States to southeast Asian refugees. N. Engl. J. 
   Med., 321 :1301-1305, 1989. 
9) Gall JAM, Bhathal PS: Development of 
   intrahepatic bile ducts in rat foetal liver explanta 
   in vitro. J. Exp. Med., 71 :41--50, 1990. 
10) Hoofnagle JH : Toward universal vaccination 
   against hepatitis B virus. N Engl. J. Med., 321 
  1333-1334, 1989. 
11) Jorgensen MJ : The ductal plate malformation. 
  A study of the intrahepatic bile duct lesion in 
   infantile polycystic disease and congenital
   hepatic fibrosis. Acta Pathol. Micro biol.
   Immunol. Scand. A SuppL, 257:33-88, 1976. 
12) Karayiannis P, Novick DM, Lok ASF, Fowler 
   MJF, Monjardino J, Thomas HC : Hepatitis B 
   virus DNA in saliva, urine and seminal fluid of
   carriers of hepatitis B e antigen. Br. Med. J., 
  290:1853-1855, 1985. 
13) Kawano Y : Localization of hepatitis B surface 
   antigen in hepatocellular carcinoma. Acta 
   Pathol. Jpn., 33:1087-1093, 1983. 
14) Michalak T : Immune complexes of hepatitis B 
   surface antigen in the pathogenesis of periar-
   teritis nodoza. Am. J. Pathol., 90:619-632, 1978. 
15) Nayak NC, Sachdeva R : Localization of 
   hepatitis B surface antigen in conventional 
   paraffin sections of the liver. Am. J. Pathol., 
  81 :479-492, 1975. 
16) Nazarewicz T, Krawczynski K, Slusarczyk J, 
   Nowoslawski A : Cellular localization of 
  hepatitis B virus antigens in patients with 
   hepatocellular carcinoma coexisting with liver 
   cirrhosis. J. Infect. Dis., 135:298-302, 1977. 
17) Nowoslawski A, Krzysztof K, Brzosko WJ, 
  Madalinski K : Tissue localization of Australia 
   antigen immune complexes in acute and chronic 
   hepatitis and liver cirrhosis. Am. J. Pathol., 68: 
  31-56, 1972. 
18) Senba M : Localization of hepatitis B surface 
   antigen in the pancreas and hepatocellular 
   carcinoma. Kyusyu Clin. Pathol., 18:106, 1981. 
19) Senba M : Staining method for hepatitis B 
  surface antigen (HBsAg) and its mechanism. 
   Am. J. Clin. Pathol., 77:312-315, 1982.
20) Senba M, Nakamura T, Itakura H : Statistical 
   analysis of relationship between iron accu-
   mulation and hepatitis B surface antigen. Am. 
   J. Clin. Pathol., 84:340-342, 1985. 
21) Senba M, Nakamura T, Toda T, Matsumura H: 
   Decreasing frequency, with time, of hepatitis B 
   surface antigen positive liver biopsy in hepatitis, 
   cirrhosis, and hepatocellular carcinoma. Lancet, 
   1: 588-589, 1988. 
22) Shah KD, Gerber MA: Development of 
   intrahepatic bile ducts in humans. Arch. Pathol.
   Lab. Med., 113:1135-1138, 1989. 
23) Shimaba T, Shikata T, Karasawa T, Tsukagoshi 
   S, Yoshimura M, Sakurai I: Light microscopic 
   localization of hepatitis B virus antigens in the 
   human pancreas. Gastoroenterology, 81 :998-1005, 
  1981. 
24) Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas 
   GN, Nair PV, Gudavalli M, Krugaman S : 
   Perinatal hepatitis B virus transmission in the
   United States. Prevention by passive-active 
   immunization. JAMA, 253:1740-1745, 1985. 
25) Yoshimura M, Sakurai I, Shimada T, Abe K, 
  Okano T, Shikata T : Detection of HBsAg in the 
   pancreas. Acta Pathol. Jpn., 31 :711-717, 1981. 
26) Wu PC: Patterns of hepatitis B surface antigen. 
   Arch. Pathol. Lab. Med., 103:165-168, 1979.
